Related Experiment Video
Updated: Jul 15, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement
Pavel Strnad1, Masaru Harada, Matthew Siegel
1Department of Medicine, Palo Alto VA Medical Center, Palo Alto, California, USA.
Background & Aims:
Mallory body (MB) inclusions are a characteristic feature of several liver disorders and share similarities with cytoplasmic inclusions observed in neural diseases and myopathies. MBs consist primarily of keratins 8 and 18 (K8/K18), require a K8-greater-than-K18 ratio for their formation, and contain glutamine-lysine cross-links generated by transglutaminase (TG). We hypothesized that protein transamidation is essential for MB formation.
Methods:
Because TG2 is the most abundant hepatocyte TG, we tested our hypothesis using TG2(-/-) and their wild-type counterpart mice fed 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), an established MB inducer. Keratin cross-linking was further examined using recombinant proteins or transgenic mice that overexpress K8 or K18.
Results:
TG2(-/-) livers have markedly reduced TG2 activity as compared with TG2(+/+) livers. The DDC-fed TG2(-/-) mice have dramatic decreases in MB formation and liver hypertrophy response as contrasted with DDC-fed TG2(+/+) mice. Despite similar hepatocellular damage, TG2(-/-) mice had more gallstones, jaundice, and ductal proliferation than wild-type mice. Inhibition of MB formation in TG2(-/-) mice was associated with marked attenuation of ubiquitination and K8-containing protein cross-linking. MB formation and resolution paralleled the generation then disappearance of cross-linked K8, respectively. K8 is a preferential TG2 substrate when compared to K18, as examined in vitro or in DDC-fed transgenic mice that overexpress K8 or K18.
Conclusions:
We demonstrate an essential role for TG2 in determining injury-mediated liver enlargement and the necessity of K8 and TG2 for generating cross-linked keratins and MBs. The role of TG in inclusion formation might extend to nonkeratin intermediate filament protein-related diseases.
Insights
Transglutaminase 2 (TG2) is essential for Mallory body (MB) formation in liver injury. TG2 activity and keratin 8 (K8) cross-linking are required for MBs and liver enlargement.
Area of Science:
- Hepatology
- Cell Biology
- Biochemistry
Background:
- Mallory bodies (MBs) are characteristic inclusions in liver diseases, primarily composed of keratins 8 and 18 (K8/K18).
- MB formation requires a specific K8/K18 ratio and glutamine-lysine cross-links mediated by transglutaminase (TG).
Purpose of the Study:
- To investigate the essential role of protein transamidation, specifically TG2, in MB formation.
- To elucidate the relationship between TG2, keratin cross-linking, and liver injury responses.
Main Methods:
- Utilized TG2 knockout (TG2-/-) and wild-type mice treated with 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), an MB inducer.
- Examined keratin cross-linking using recombinant proteins and transgenic mice overexpressing K8 or K18.
Main Results:
- TG2-/- mice exhibited significantly reduced MB formation and liver hypertrophy compared to wild-type mice following DDC administration.
- Reduced TG2 activity in TG2-/- mice correlated with decreased K8-containing protein cross-linking and ubiquitination.
- K8 was identified as a preferential TG2 substrate over K18 in vitro and in vivo.
Conclusions:
- TG2 plays a critical role in mediating injury-induced liver enlargement and MB formation.
- The formation of cross-linked keratins and MBs necessitates both K8 and TG2.
- TG-mediated cross-linking may be a common mechanism in various intermediate filament protein-related diseases.
Related Concept Videos
Cirrhosis II: Pathophysiology
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Acute Pancreatitis II: Pathophysiology
Chronic Inflammation: Introduction
